Literature DB >> 46513

Uracil-specific anti-R.N.A. antibodies in scleroderma.

D Alarcón-Segovia, E Fishbein, E García-Ortigoza, S Estrada-Parra.   

Abstract

Antibodies to single-stranded R.N.A. were found by counter immunoelectrophoresis in all of 40 sera from patients with scleroderma. These antibodies were specific to the uracil bases of R.N.A. Antibodies to R.N.A. were also found in 20 of 40 sera from patients with systemic lupus erythematosus (S.L.E.), but in none of forty controls. Antibodies to R.N.A. found in S.L.E. sera could be differentiated immunochemically from those found in scleroderma in that they were more heterogeneous and could react selectively with either uridine or uridine monophosphate. Antibodies ot D.N.A. were more frequent in S.L.E. than in scleroderma. That antibodies to D.N.A. are actually present in scleroderma and precipitin lines are not the result of cross reactivity with anti-R.N.A. antibodies is indicated by the finding that 10 of the 18 scleroderma sera which reacted with D.N.A. also reacted with thymidine, a base present in D.N.A. but not in R.N.A.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46513     DOI: 10.1016/s0140-6736(75)91279-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  15 in total

1.  Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides.

Authors:  D Alarcón-Segovia; E Fishbein; S Estrada-Parra; E García-Ortigoza
Journal:  Immunology       Date:  1976-03       Impact factor: 7.397

Review 2.  B-cell epitopes of RNA autoantigens.

Authors:  R M Hoet; W J van Venrooij
Journal:  Mol Biol Rep       Date:  1992-06       Impact factor: 2.316

3.  Lymphokine stimulation of collagen accumulation.

Authors:  R L Johnson; M Ziff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 4.  Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses.

Authors:  E M Sternberg
Journal:  Surv Immunol Res       Date:  1985

5.  The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.

Authors:  P Hughes; S Holt; N R Rowell; I D Allonby; K Janis; J K Dodd
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

6.  Serological markers in progressive systemic sclerosis: clinical correlations.

Authors:  L J Catoggio; R M Bernstein; C M Black; G R Hughes; P J Maddison
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

7.  Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.

Authors:  C G Kallenberg; J M Van der Voort-Beelen; J D'Amaro; T H The
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

8.  Lymphocyte cytotoxicity in systemic sclerosis: no increase on short-term culture with established human cell lines.

Authors:  J K Wright; P Hughes; N R Rowell
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

9.  Spontaneous lymphocyte-mediated (NK cell) cytotoxicity in systemic sclerosis: a comparison with antibody-dependent lymphocyte (K cell) cytotoxicity.

Authors:  J K Wright; P Hughes; N R Rowell
Journal:  Ann Rheum Dis       Date:  1982-08       Impact factor: 19.103

10.  Monocyte-induced inhibition of lymphocyte response to phytohaemagglutinin in progressive systemic sclerosis.

Authors:  M D Lockshin; J A Markenson; L Fuzesi; S Kazanjian-Aram; C Joachim; M Ordene
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.